Certoparin

DRUG4 trials

Sponsors

Novartis, Novartis Pharmaceuticals

Conditions

EmbolismPersistent Nonvalvular Atrial FibrillationRenal DialysisThromboembolism

Phase 3

Atrial Fibrillation Feasibility Certoparin Trial - AFFECT

CompletedNCT00171769

NovartisPersistent Nonvalvular Atrial Fibrillation

Start: 2005-04-30Target: 200Updated: 2017-02-23

Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients

CompletedNCT00311753

Novartis PharmaceuticalsEmbolism

Start: 2006-02-28Updated: 2017-02-24

A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients

CompletedNCT00451412

NovartisThromboembolism

Start: 2007-01-31End: 2009-06-30Updated: 2012-07-25

Certoparin in Renal Patients Undergoing Hemodialysis

CompletedNCT01179620

NovartisRenal Dialysis

Start: 2010-11-30End: 2011-03-31Updated: 2012-07-10

Related Papers

Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.

2011-07-2626 citations